Texas SB670 allows patients to access investigational sun protection products with physician consent and informed consent.

Texas SB670 amends the Health and Safety Code to create a new chapter on patient access to investigational sun protection products. The bill defines "investigational sun protection product" as a product containing an ingredient that has completed phase one of a clinical trial but has not yet been approved for general use by the FDA. Patients are eligible to access these products if their physician considers all approved products and determines the investigational product is more effective.

Texas SB670 allows patients to access investigational sun protection products with physician consent and informed consent.

Texas SB670 amends the Health and Safety Code to create a new chapter on patient access to investigational sun protection products. The bill defines "investigational sun protection product" as a product containing an ingredient that has completed phase one of a clinical trial but has not yet been approved for general use by the FDA. Patients are eligible to access these products if their physician considers all approved products and determines the investigational product is more effective.